News
07-15-2009, 05:10 AM
Quantum Immunologics, Inc. (QI), a Tampa, Florida company focusing on the research and development of cancer immunotherapies, announces that the first patient in its breast cancer trial has begun to receive its dendritic cell therapy. QI is currently sponsoring and conducting an FDA-authorized Phase I/II clinical trial testing the safety and efficacy of its immunotherapy on 27 Stage IV breast cancer patients who have failed conventional therapy. According to Mr.
More... (http://www.medicalnewstoday.com/articles/157514.php)
More... (http://www.medicalnewstoday.com/articles/157514.php)